March 21, 2018 / 12:14 PM / a month ago

BRIEF-TCR2 Therapeutics Raises $125 Mln In Oversubscribed Series B Financing

March 21 (Reuters) - TCR2 Therapeutics:

* TCR2 THERAPEUTICS RAISES $125 MILLION IN OVERSUBSCRIBED SERIES B FINANCING

* TCR2 THERAPEUTICS INC - FINANCING WAS CO-LED BY 6 DIMENSIONS CAPITAL AND CURATIVE VENTURES

* TCR2 THERAPEUTICS - PROCEEDS TO SUPPORT DEVELOPMENT OF LEAD PROGRAM AND EXPANSION OF MULTI-FORMAT TRUC-T CELL PIPELINE IN SOLID TUMORS, BLOOD CANCERS

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below